481 related articles for article (PubMed ID: 21538846)
1. Cancer chemoprevention with green tea catechins by targeting receptor tyrosine kinases.
Shimizu M; Adachi S; Masuda M; Kozawa O; Moriwaki H
Mol Nutr Food Res; 2011 Jun; 55(6):832-43. PubMed ID: 21538846
[TBL] [Abstract][Full Text] [Related]
2. (-)-Epigallocatechin gallate inhibits growth and activation of the VEGF/VEGFR axis in human colorectal cancer cells.
Shimizu M; Shirakami Y; Sakai H; Yasuda Y; Kubota M; Adachi S; Tsurumi H; Hara Y; Moriwaki H
Chem Biol Interact; 2010 May; 185(3):247-52. PubMed ID: 20346928
[TBL] [Abstract][Full Text] [Related]
3. Targeting receptor tyrosine kinases for chemoprevention by green tea catechin, EGCG.
Shimizu M; Shirakami Y; Moriwaki H
Int J Mol Sci; 2008 Jun; 9(6):1034-1049. PubMed ID: 19325845
[TBL] [Abstract][Full Text] [Related]
4. Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate.
Khan N; Afaq F; Saleem M; Ahmad N; Mukhtar H
Cancer Res; 2006 Mar; 66(5):2500-5. PubMed ID: 16510563
[TBL] [Abstract][Full Text] [Related]
5. (-)-Epigallocatechin gallate suppresses the growth of human hepatocellular carcinoma cells by inhibiting activation of the vascular endothelial growth factor-vascular endothelial growth factor receptor axis.
Shirakami Y; Shimizu M; Adachi S; Sakai H; Nakagawa T; Yasuda Y; Tsurumi H; Hara Y; Moriwaki H
Cancer Sci; 2009 Oct; 100(10):1957-62. PubMed ID: 19558547
[TBL] [Abstract][Full Text] [Related]
6. The inhibitory effect of (-)-epigallocatechin gallate on activation of the epidermal growth factor receptor is associated with altered lipid order in HT29 colon cancer cells.
Adachi S; Nagao T; Ingolfsson HI; Maxfield FR; Andersen OS; Kopelovich L; Weinstein IB
Cancer Res; 2007 Jul; 67(13):6493-501. PubMed ID: 17616711
[TBL] [Abstract][Full Text] [Related]
7. EGCG inhibits activation of the insulin-like growth factor-1 receptor in human colon cancer cells.
Shimizu M; Deguchi A; Hara Y; Moriwaki H; Weinstein IB
Biochem Biophys Res Commun; 2005 Sep; 334(3):947-53. PubMed ID: 16053920
[TBL] [Abstract][Full Text] [Related]
8. New cancer treatment strategy using combination of green tea catechins and anticancer drugs.
Suganuma M; Saha A; Fujiki H
Cancer Sci; 2011 Feb; 102(2):317-23. PubMed ID: 21199169
[TBL] [Abstract][Full Text] [Related]
9. Multistage carcinogenesis process as molecular targets in cancer chemoprevention by epicatechin-3-gallate.
Pan MH; Chiou YS; Wang YJ; Ho CT; Lin JK
Food Funct; 2011 Feb; 2(2):101-10. PubMed ID: 21779554
[TBL] [Abstract][Full Text] [Related]
10. Tea catechins as inhibitors of receptor tyrosine kinases: mechanistic insights and human relevance.
Larsen CA; Dashwood RH; Bisson WH
Pharmacol Res; 2010 Dec; 62(6):457-64. PubMed ID: 20691268
[TBL] [Abstract][Full Text] [Related]
11. Tea polyphenol (-)-epigallocatechin 3-gallate suppresses heregulin-beta1-induced fatty acid synthase expression in human breast cancer cells by inhibiting phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase cascade signaling.
Pan MH; Lin CC; Lin JK; Chen WJ
J Agric Food Chem; 2007 Jun; 55(13):5030-7. PubMed ID: 17539658
[TBL] [Abstract][Full Text] [Related]
12. The effect of green tea extract and EGCG on the signaling network in squamous cell carcinoma.
Liu X; Zhang DY; Zhang W; Zhao X; Yuan C; Ye F
Nutr Cancer; 2011; 63(3):466-75. PubMed ID: 21391127
[TBL] [Abstract][Full Text] [Related]
13. EGCG inhibits activation of the insulin-like growth factor (IGF)/IGF-1 receptor axis in human hepatocellular carcinoma cells.
Shimizu M; Shirakami Y; Sakai H; Tatebe H; Nakagawa T; Hara Y; Weinstein IB; Moriwaki H
Cancer Lett; 2008 Apr; 262(1):10-8. PubMed ID: 18164805
[TBL] [Abstract][Full Text] [Related]
14. EGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cells.
Jung YD; Kim MS; Shin BA; Chay KO; Ahn BW; Liu W; Bucana CD; Gallick GE; Ellis LM
Br J Cancer; 2001 Mar; 84(6):844-50. PubMed ID: 11259102
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor receptor tyrosine kinase inhibitors as potential cancer chemopreventives.
Kelloff GJ; Fay JR; Steele VE; Lubet RA; Boone CW; Crowell JA; Sigman CC
Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):657-66. PubMed ID: 8824370
[TBL] [Abstract][Full Text] [Related]
16. Potential molecular targets of tea polyphenols in human tumor cells: significance in cancer prevention.
Kazi A; Smith DM; Daniel K; Zhong S; Gupta P; Bosley ME; Dou QP
In Vivo; 2002; 16(6):397-403. PubMed ID: 12494882
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of tumor promoter-induced activator protein 1 activation and cell transformation by tea polyphenols, (-)-epigallocatechin gallate, and theaflavins.
Dong Z; Ma W; Huang C; Yang CS
Cancer Res; 1997 Oct; 57(19):4414-9. PubMed ID: 9331105
[TBL] [Abstract][Full Text] [Related]
18. Epigallocatechin-3-Gallate suppresses early stage, but not late stage prostate cancer in TRAMP mice: mechanisms of action.
Harper CE; Patel BB; Wang J; Eltoum IA; Lamartiniere CA
Prostate; 2007 Oct; 67(14):1576-89. PubMed ID: 17705241
[TBL] [Abstract][Full Text] [Related]
19. The green tea compound, (-)-epigallocatechin-3-gallate downregulates N-cadherin and suppresses migration of bladder carcinoma cells.
Rieger-Christ KM; Hanley R; Lodowsky C; Bernier T; Vemulapalli P; Roth M; Kim J; Yee AS; Le SM; Marie PJ; Libertino JA; Summerhayes IC
J Cell Biochem; 2007 Oct; 102(2):377-88. PubMed ID: 17348027
[TBL] [Abstract][Full Text] [Related]
20. Combined inhibitory effects of green tea polyphenols and selective cyclooxygenase-2 inhibitors on the growth of human prostate cancer cells both in vitro and in vivo.
Adhami VM; Malik A; Zaman N; Sarfaraz S; Siddiqui IA; Syed DN; Afaq F; Pasha FS; Saleem M; Mukhtar H
Clin Cancer Res; 2007 Mar; 13(5):1611-9. PubMed ID: 17332308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
